UNSPSC 51112507: Cyclophosphamide

This classification denotes a nitrogen mustard compound and immunosuppressant with the molecular formula C7H15Cl2N2O2P.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8N3DW7272P, chemically known as 2h-1,3,2-oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-, 2-oxide but more generally known as cyclophosphamide, which bears US NIH Compound Identifier 2907. European Medicines Agency schedules Cyclophosphamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06859MIG.

UNSPSC 51112507 Cyclophosphamide is a Commodity code for a specific chemotherapy agent that state and local health systems procure as part of oncology treatment protocols and institutional pharmacy stock. State and local governments buy cyclophosphamide through hospital pharmacy procurement, public health departments managing cancer treatment programs, correctional health services, and veteran health facilities operated or funded by state and local authorities. The drug is purchased in bulk or unit quantities — typically as injectable or oral formulations — to support inpatient chemotherapy wards, outpatient infusion centers, and specialty pharmacy networks serving Medicaid and indigent-care populations.

The source provided contains no recent state and local contract opportunities tagged to this code. Without posted RFP, RFQ, IFB, or ITB records showing active procurement under UNSPSC 51112507, geographic concentration and issuing-body patterns cannot be characterized from current solicitation activity.